Unknown

Dataset Information

0

A Dual Reporter Iodinated Labeling Reagent for Cancer Positron Emission Tomography Imaging and Fluorescence-Guided Surgery.


ABSTRACT: The combination of early diagnosis and complete surgical resection offers the greatest prospect of curative cancer treatment. An iodine-124/fluorescein-based dual-modality labeling reagent, 124I-Green, constitutes a generic tool for one-step installation of a positron emission tomography (PET) and a fluorescent reporter to any cancer-specific antibody. The resulting antibody conjugate would allow both cancer PET imaging and intraoperative fluorescence-guided surgery. 124I-Green was synthesized in excellent radiochemical yields of 92 ± 5% (n = 4) determined by HPLC with an improved one-pot three-component radioiodination reaction. The A5B7 carcinoembryonic antigen (CEA)-specific antibody was conjugated to 124I-Green. High tumor uptake of the dual-labeled A5B7 of 20.21 ± 2.70, 13.31 ± 0.73, and 10.64 ± 1.86%ID/g was observed in CEA-expressing SW1222 xenograft mouse model (n = 3) at 24, 48, and 72 h post intravenous injection, respectively. The xenografts were clearly visualized by both PET/CT and ex vivo fluorescence imaging. These encouraging results warrant the further translational development of 124I-Green for cancer PET imaging and fluorescence-guided surgery.

SUBMITTER: Lu Z 

PROVIDER: S-EPMC5847118 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Dual Reporter Iodinated Labeling Reagent for Cancer Positron Emission Tomography Imaging and Fluorescence-Guided Surgery.

Lu Zhi Z   Pham Truc Thuy TT   Rajkumar Vineeth V   Yu Zilin Z   Pedley R Barbara RB   Årstad Erik E   Maher John J   Yan Ran R  

Journal of medicinal chemistry 20180206 4


The combination of early diagnosis and complete surgical resection offers the greatest prospect of curative cancer treatment. An iodine-124/fluorescein-based dual-modality labeling reagent, <sup>124</sup>I-Green, constitutes a generic tool for one-step installation of a positron emission tomography (PET) and a fluorescent reporter to any cancer-specific antibody. The resulting antibody conjugate would allow both cancer PET imaging and intraoperative fluorescence-guided surgery. <sup>124</sup>I-G  ...[more]

Similar Datasets

| S-EPMC8952779 | biostudies-literature
| S-EPMC7252900 | biostudies-literature
| S-EPMC6430723 | biostudies-literature
| S-EPMC4995128 | biostudies-literature
2015-02-09 | E-MTAB-3175 | biostudies-arrayexpress
| S-EPMC3163899 | biostudies-literature
2011-11-01 | GSE21217 | GEO
| S-EPMC2759299 | biostudies-literature
| S-EPMC10722030 | biostudies-literature
| S-EPMC3249097 | biostudies-literature